← All trials
NCT04614740
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 20, 2020
- Primary completion
- Jan 31, 2024
- Completion date
- Jun 30, 2024
- First posted
- Nov 4, 2020
- Last posted
- Dec 10, 2020
- Enrollment
- 115
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Jiangsu vcare pharmaceutical technology co., LTDLead sponsor
- Peking UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.